Breaking News

Eurofins CDMO Alphora Completes New API Manufacturing Facility

The new API facility adds 15,000 sq.-ft. of GMP processing and warehousing space, expanding its capacity and capabilities.

Author Image

By: Charlie Sternberg

Associate Editor

Eurofins CDMO Alphora Inc. has expanded its API capacity and capabilities with the completion of its new API manufacturing facility at its site in Mississauga, Canada. The new API facility adds 15,000 sq.-ft. of GMP processing and warehousing space which complements Eurofins CDMO Alphora’s existing API and drug substance manufacturing capabilities. The addition of 2 x 2000 L reactors expands existing GMP plant capacity and supports API batches to the 125kg scale. The new plant provides a...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters